116 related articles for article (PubMed ID: 29550845)
1. Correlations between dual-phase 18F-FDG uptake and clinicopathologic and biological markers of breast cancer.
Kaida H; Azuma K; Toh U; Kawahara A; Sadashima E; Hattori S; Akiba J; Tahara N; Rominger A; Ishii K; Murakami T; Ishibashi M
Hell J Nucl Med; 2018; 21(1):35-42. PubMed ID: 29550845
[TBL] [Abstract][Full Text] [Related]
2. The maximum standardized uptake value of metastatic site in 18 F-FDG PET/CT predicts molecular subtypes and survival in metastatic breast cancer: An Izmir Oncology Group study.
Cokmert S; Tanriverdi O; Karapolat I; Demir L; Bayoglu V; Can A; Akyol M; Yilmaz Y; Oktay Tarhan M
J BUON; 2016; 21(6):1410-1418. PubMed ID: 28039701
[TBL] [Abstract][Full Text] [Related]
3. Relationship between retention index in dual-phase (18)F-FDG PET, and hexokinase-II and glucose transporter-1 expression in pancreatic cancer.
Higashi T; Saga T; Nakamoto Y; Ishimori T; Mamede MH; Wada M; Doi R; Hosotani R; Imamura M; Konishi J
J Nucl Med; 2002 Feb; 43(2):173-80. PubMed ID: 11850481
[TBL] [Abstract][Full Text] [Related]
4. Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.
Basu S; Chen W; Tchou J; Mavi A; Cermik T; Czerniecki B; Schnall M; Alavi A
Cancer; 2008 Mar; 112(5):995-1000. PubMed ID: 18098228
[TBL] [Abstract][Full Text] [Related]
5. Correlation of the value of 18F-FDG uptake, described by SUVmax, SUVavg, metabolic tumour volume and total lesion glycolysis, to clinicopathological prognostic factors and biological subtypes in breast cancer.
Kajáry K; Tőkés T; Dank M; Kulka J; Szakáll S; Lengyel Z
Nucl Med Commun; 2015 Jan; 36(1):28-37. PubMed ID: 25299471
[TBL] [Abstract][Full Text] [Related]
6. Correlation of hypoxia inducible transcription factor in breast cancer and SUVmax of F-18 FDG PET/CT.
Jeong YJ; Jung JW; Cho YY; Park SH; Oh HK; Kang S
Nucl Med Rev Cent East Eur; 2017; 20(1):32-38. PubMed ID: 28198519
[TBL] [Abstract][Full Text] [Related]
7. Tumour and lymph node uptakes on dual-phased 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography/computed tomography correlate with prognostic parameters in breast cancer.
Chang CC; Tu HP; Chen YW; Lin CY; Hou MF
J Int Med Res; 2014 Dec; 42(6):1209-21. PubMed ID: 25339454
[TBL] [Abstract][Full Text] [Related]
8. Prediction of biological characteristics of breast cancer using dual-phase FDG PET/CT.
Sasada S; Masumoto N; Suzuki E; Sueoka S; Goda N; Kajitani K; Emi A; Kadoya T; Okada M
Eur J Nucl Med Mol Imaging; 2019 Apr; 46(4):831-837. PubMed ID: 30648199
[TBL] [Abstract][Full Text] [Related]
9. Role of FDG-PET/CT in evaluating surgical outcomes of operable breast cancer--usefulness for malignant grade of triple-negative breast cancer.
Ohara M; Shigematsu H; Tsutani Y; Emi A; Masumoto N; Ozaki S; Kadoya T; Okada M
Breast; 2013 Oct; 22(5):958-63. PubMed ID: 23756383
[TBL] [Abstract][Full Text] [Related]
10. Association between partial-volume corrected SUVmax and Oncotype DX recurrence score in early-stage, ER-positive/HER2-negative invasive breast cancer.
Lee SH; Ha S; An HJ; Lee JS; Han W; Im SA; Ryu HS; Kim WH; Chang JM; Cho N; Moon WK; Cheon GJ
Eur J Nucl Med Mol Imaging; 2016 Aug; 43(9):1574-84. PubMed ID: 27209424
[TBL] [Abstract][Full Text] [Related]
11. Molecular biological correlation of fluorine-18 fluorodeoxyglucose uptake in esophageal squamous cell carcinoma.
Hirose Y; Kaida H; Kawahara A; Matono S; Tanaka T; Kurata S; Kage M; Ishibashi M; Abe T
Nucl Med Commun; 2016 Oct; 37(10):1053-61. PubMed ID: 27218430
[TBL] [Abstract][Full Text] [Related]
12. Strong association of epidermal growth factor receptor status with breast cancer FDG uptake.
Lee J; Lee EJ; Moon SH; Kim S; Hyun SH; Cho YS; Choi JY; Kim BT; Lee KH
Eur J Nucl Med Mol Imaging; 2017 Aug; 44(9):1438-1447. PubMed ID: 28488029
[TBL] [Abstract][Full Text] [Related]
13. 18F-FDG uptake by metastatic axillary lymph nodes on pretreatment PET/CT as a prognostic factor for recurrence in patients with invasive ductal breast cancer.
Song BI; Lee SW; Jeong SY; Chae YS; Lee WK; Ahn BC; Lee J
J Nucl Med; 2012 Sep; 53(9):1337-44. PubMed ID: 22870824
[TBL] [Abstract][Full Text] [Related]
14. 18F-FDG uptake in squamous cell carcinoma of the cervix is correlated with glucose transporter 1 expression.
Yen TC; See LC; Lai CH; Yah-Huei CW; Ng KK; Ma SY; Lin WJ; Chen JT; Chen WJ; Lai CR; Hsueh S
J Nucl Med; 2004 Jan; 45(1):22-9. PubMed ID: 14734665
[TBL] [Abstract][Full Text] [Related]
15. The Clinical Role of Dual-Time-Point (18)F-FDG PET/CT in Differential Diagnosis of the Thyroid Incidentaloma.
Lee S; Park T; Park S; Pahk K; Rhee S; Cho J; Jeong E; Kim S; Choe JG
Nucl Med Mol Imaging; 2014 Jun; 48(2):121-9. PubMed ID: 24900152
[TBL] [Abstract][Full Text] [Related]
16. Positron emission mammography: correlation of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 status and 18F-FDG.
Wang CL; MacDonald LR; Rogers JV; Aravkin A; Haseley DR; Beatty JD
AJR Am J Roentgenol; 2011 Aug; 197(2):W247-55. PubMed ID: 21785049
[TBL] [Abstract][Full Text] [Related]
17. The relationship between 18F-FDG metabolic volumetric parameters and clinicopathological factors of breast cancer.
Kaida H; Toh U; Hayakawa M; Hattori S; Fujii T; Kurata S; Kawahara A; Hirose Y; Kage M; Ishibashi M
Nucl Med Commun; 2013 Jun; 34(6):562-70. PubMed ID: 23619341
[TBL] [Abstract][Full Text] [Related]
18. Associations between the standardized uptake value of (18)F-FDG PET/CT and the prognostic factors of invasive lobular carcinoma: in comparison with invasive ductal carcinoma.
Jung NY; Kim SH; Choi BB; Kim SH; Sung MS
World J Surg Oncol; 2015 Mar; 13():113. PubMed ID: 25889560
[TBL] [Abstract][Full Text] [Related]
19. Dual-phase 18F-fluoro-2-deoxy-D-glucose positron emission tomography as a prognostic parameter in patients with pancreatic cancer.
Lyshchik A; Higashi T; Nakamoto Y; Fujimoto K; Doi R; Imamura M; Saga T
Eur J Nucl Med Mol Imaging; 2005 Apr; 32(4):389-97. PubMed ID: 15372209
[TBL] [Abstract][Full Text] [Related]
20. 18F-fluoro-2-deoxy-D-glucose retention index as a prognostic parameter in patients with pancreatic cancer.
Xi Y; Guo R; Hu J; Zhang M; Zhang X; Li B
Nucl Med Commun; 2014 Nov; 35(11):1112-8. PubMed ID: 25098308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]